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Background: To investigate the role of prolyl hydroxylase (PH), a key enzyme of collagen synthesis, in human
uterine leiomyoma, PH expression was determined in the normal uterine myometrium and the leiomyoma tissues
during the menstrual cycle.
Methods: The tissues were obtained from 40 regularly cycling women (aged 29 to 53 yr) who were undergoing
abdominal hysterectomy for symptomatic uterine leiomyoma. Immunohistochemistry for human PH with specific
monoclonal antibody was used for analysis.
Results: Immunohistochemical staining for PH revealed intense staining of leiomyoma cells in the uterine
leiomyoma throughout the menstrual cycle, as compared with the adjacent normal myometrium. In the secretory
phase, weak or no immunostaining for PH was detected in the normal myometrial tissues.
Conclusions: These results suggest that increased expression of PH might play an role in the physiology of uterine
leiomyoma during the menstrual cycle.
Keywords: Prolyl hydroxylase, Human uterine myometrium, Leiomyoma, ImmunohistochemistryBackground
The extracellular matrix (ECM) is considered to play an
important role in the stability of tissues and in regulating
the growth and differentiation of cells [1,2].
Synthesis, accumulation, and catabolism of the ECM
occur during wound healing and during the initiation
and progression of numerous diseases [3]. Moreover, it
is generally acknowledged that the ECM does not func-
tion as a mere passive scaffold for connective tissue
within organ architecture. It is also suggested that ECM
plays an ‘informational’ role through a network of inter-
actions between cells and signal molecules that is of pri-
mary importance in the control of cellular proliferation
and motility during histogenesis, for the maintenance of
tissue homeostasis and in cancer development. The
ECM of uterine leiomyoma has been studied [4-7], but
changes of the collagen metabolism in uterine tissues are
not fully understood. Therefore, the precise control of
ECM metabolism in the uterine myoma and myometrium* Correspondence: masaaki@wakayama-med.ac.jp
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reproduction in any medium, provided the oris critical for understanding the pathophysiology and
development of uterine leiomyoma.
Most of the 4-hydroxyproline in mammalian proteins
is found in the -X-4Hyp-Gly- sequences of the 29
currently known collagen types and more than 20
additional proteins with collagen–like triple-helical
domains [8,9]. 4-Hydroxyproline residues have a vital
role in providing the collagen triple helices with ther-
mal stability. Non-hydroxylated collagen polypeptide
chains cannot form functional molecules in vitro, and
almost complete hydroxylation of the proline residues
in –X-Pro-Gly- triplets is required for the generation of
a molecule that is stable at human body temperature.
This hydroxylation is catalyzed by collagen prolyl
hydroxylase (PH) located within the lumen of the endo-
plasmic reticulum [10]. Therefore, in the present study,
we investigated the distribution of human PH, a key en-
zyme in the synthesis of collagen [11,12], in human
uterine leiomyoma by immunofluorescent staining.Methods
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from each subject after the purpose and nature of the
study had been fully explained.
Tissues
Leiomyomas and matched myometrium were processed
for immunohistochemistry. The tissues were obtained
from 40 premenopausal regularly cycling women
(aged 29 to 53 yr) who were undergoing abdominal hys-
terectomy for symptomatic uterine leiomyoma. None of
the patients received any hormone therapy before oper-
ation. The stage of menstrual cycle was determined by
histological dating of the endometrium for all secretory
phase samples. Proliferative phase samples were dated
by either dating of the endometrium or date of last men-
strual period. The leiomyoma and corresponding
myometrium specimens from the proliferative (n = 20)
and secretory (n = 20) phase were studied. No submuco-
sal leiomyomas were collected so as to avoid possible
contamination with endometrium. Three distant samples
were collected from each leiomyoma and adjacent nor-
mal myomerial tissues. These tissues were immediately
frozen in liquid nitrogen.
Primary antibodies
We used the monoclonal antibodies (mAbs) against of
hPH (anti-hPH(β); horseradish peroxidase-conjugated
Fab’ (Fab’-HRP)), which recognized the β subunit of pro-
lyl hydroxylase, were prepared as described by Bai et al.
[13]. Preparation of the antibodies has been performed
as described previously [14]. The specificity of the anti-
bodies was determined by immunoblotting or by inhib-
ition in an enzyme-linked immunosorbent assay.
Immunohistochemistry
Immunohistochemical analysis was performed by the
standard indirect immunofluorescence method. In brief,
3-μm frozen sections were rehydrated in phosphate-
buffered saline (PBS) at room temperature and thenFigure 1 Immunofluorescence micrographs of human uterine leiomyo
human PH. The micrographs of leiomyoma are B and D, and the microgra
(proliferative phase: B and C; secretory phase: D and E). No immunofluores
magnification, X 125) Scale bar represents 50 μm.incubated with the primary antibody (diluted 1: 100 in
PBS) for 12 h at 4°C in a humidified chamber. After incu-
bation, the sections were washed twice in PBS for 3 min.
Each section was then incubated for 1 h at room
temperature with human plasma-preabsorbed, fluorescein
isothiocyanate-conjugated goat antibodies against mouse
immunoglobulins diluted 1:100 in PBS (Organon Teknik,
Co., West Chester, PA).
Control sections were stained with goat antibodies
against mouse immunoglobulin G without prior applica-
tion of the primary antibodies. No immunofluorescence
was recognized in control sections (Figure 1A). When
the mAb was first allowed to react with an excess of hPH ,
no immunostaining was observed (data not shown).Results
Immunostaining with the mAbs against hPH showed in-
tense granular pattern in the cytoplasm of leiomyoma cells
as compared with the normal uterine myometrial tissues
throughout the menstrual cycle consistently (Figure 1B
and D). Immunostaining for hPH showed intense granular
pattern in the cytoplasm of the normal myometrial cells in
the proliferative phase (Figure 1C). However, weak or no
immunostaining for hPH was detected in the normal myo-
metrial tissues in the secretory phase (Figure 1E).
The intensity of staining of the uterine tissues from the
menstrual cycle by the antibodies against hPH was sub-
jectively graded from 1+ to 3+ and the results are sum-
marized in Table 1.Discussion
In the present study, we investigated the immunolocali-
zation of hPH in the human uterine tissues obtained
during the menstrual cycle. Immunostaining for hPH
was clearly apparent in the cytoplasm of the uterine leio-
myoma cells and the normal myometrial cells during the
menstrual cycle. Especially, in the uterine leiomyoma,ma and myometrium with immunostaining by mAbs specific for
phs of myometrium are C and E during the menstrual cycle
cence was recognized in the control section (A). (Original
Table 1 Immunostaining with antibodies for human
prolyl hydroxylase in the human uterine leiomyoma and
myometrium
Phase
Proliferative (n = 10) Secretory (n = 10)
Leiomyoma +++ ++
Myometrium ++ +/−
Intensities of immunostaining were int graded subjectively.
−, no staining; +, weak staining; ++, intense staining; +++, very intense
staining.
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with the normal adjacent myometrium during the men-
strual cycle. These findings suggest that leiomyoma cells
might synthesize collagens more actively than the nor-
mal myometrial cells throughout the menstrual cycle
consistently.
We have previously suggested that the increased expres-
sion of the various collagens, such as type III, IV and V
collagens, is recognized by immunohistochemistry and
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
in the human uterine leiomyoma, as compared with the
normal uterine myometrium during the menstrual cycle
[15,16]. Therefore, increased these collagens expression
might play an important role in the morphologic and
functional characteristics of human uterine leiomyoma.
PH, a key enzyme in the hydroxylation of proline to
hydroxyproline during the synthesis of collagen [11,12],
is a tetramer of two α and β subunits [17]. A cDNA se-
quence for the β subunit of hPH has been found to be
highly homologous with that for a rat protein disulfide
isomerase, which is regarded as the catalyst in vivo for
formation of disulfide bonds in the biosynthesis of vari-
ous secretory proteins [17,18]. Therefore, immunoreac-
tivity of the β subunit may reflect the enzymatic activity
of PH in collagen metabolism.
Recently, it has been suggested that oxygen-dependent
hydroxylation of hypoxia-inducible factor (HIF)- α subunits
by PH domain (PHD) proteins signals their polyubiquitina-
tion and proteasomal degradation, and a critical role in
regulating HIF abundance and oxygen homeostasis. While
oxygen concentration plays a major role in determining the
efficiency of PHD-catalyzed hydroxylation reactions, many
other environmental and intracellular factors also signifi-
cantly modulate PHD activities. In addition, PHDs may also
employ hydroxylase-independent mechanisms to modify
HIF activity. Functionally, different PHD isoforms may
differentially contribute to specific pathophysiological pro-
cesses, including angiogenesis, erythropoiesis, tumorigen-
esis, diabetes, and cell growth, differentiation and survival
[10,19-25]. Therefore, our findings support the hypothesis
that HIF-PH systems might be involved in the pathogenesis
of uterine leiomyoma during the menstrual cycle [26,27].Conclusions
An increased hPH expression was found in the uterine
leiomyoma cells of the uterine fibroids throughout the
menstrual cycle. Thus, these consistent expression of
hPH might play a role in the physiology of human uter-
ine fibroids.
This study provides some clues to understanding the
pathogenesis of human uterine leiomyoma in terms of
the, ECM metabolism. Further work is needed to eluci-
date the mechanisms regulating the HIF-PH expression
in the human uterus during the menstrual cycle and the
medical treatments.
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